[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2007144512A3 - Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires - Google Patents

Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires Download PDF

Info

Publication number
WO2007144512A3
WO2007144512A3 PCT/FR2007/000989 FR2007000989W WO2007144512A3 WO 2007144512 A3 WO2007144512 A3 WO 2007144512A3 FR 2007000989 W FR2007000989 W FR 2007000989W WO 2007144512 A3 WO2007144512 A3 WO 2007144512A3
Authority
WO
WIPO (PCT)
Prior art keywords
group
hypertension
fields
preparation
pharmaceutical compositions
Prior art date
Application number
PCT/FR2007/000989
Other languages
English (en)
Other versions
WO2007144512A2 (fr
Inventor
Alexis Cordi
Laure Haberkorn
Tony Verbeuren
Christine Courchay
Serge Simonet
Original Assignee
Servier Lab
Alexis Cordi
Laure Haberkorn
Tony Verbeuren
Christine Courchay
Serge Simonet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Alexis Cordi, Laure Haberkorn, Tony Verbeuren, Christine Courchay, Serge Simonet filed Critical Servier Lab
Publication of WO2007144512A2 publication Critical patent/WO2007144512A2/fr
Publication of WO2007144512A3 publication Critical patent/WO2007144512A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composés de formule (I) : dans laquelle : R1 représente un groupement alkanoyle, R2 représente un groupement alkyle substitué par un groupement G, ou R1 et R2 forment ensemble avec l'atome d'azote qui les porte un groupement imidazolyle ou benzimidazolyle, substitués par un groupement G, et G représente un groupement -(CH2)n-A-(CH2)m-(CR4R5)P-(CH2)O-R3 dans lequel n, m, p, o, R4, R5 et A sont tels que définis dans la description, et R3 représente un groupement formule (II) ou formule (III). Comme antagonistes des recepteurs de l'angiotensine et comme donneurs de NO, utiles dans le domaine de l'hypertension et des pathologies cardiovasculaires.
PCT/FR2007/000989 2006-06-15 2007-06-14 Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires WO2007144512A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0605318 2006-06-15
FR0605318A FR2902428B1 (fr) 2006-06-15 2006-06-15 Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
WO2007144512A2 WO2007144512A2 (fr) 2007-12-21
WO2007144512A3 true WO2007144512A3 (fr) 2008-03-20

Family

ID=37575276

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/000989 WO2007144512A2 (fr) 2006-06-15 2007-06-14 Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires

Country Status (3)

Country Link
AR (1) AR061377A1 (fr)
FR (1) FR2902428B1 (fr)
WO (1) WO2007144512A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008005484A1 (de) * 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
JP2011510082A (ja) * 2008-01-24 2011-03-31 メルク・シャープ・エンド・ドーム・コーポレイション アンジオテンシンii受容体拮抗薬
WO2009099853A2 (fr) 2008-02-08 2009-08-13 Merck & Co., Inc. Antagonistes des récepteurs de l'angiotensine ii
EP2498605B1 (fr) * 2009-10-29 2014-08-27 Merck Sharp & Dohme Corp. Diurétiques
US8648058B2 (en) 2010-02-12 2014-02-11 Merck Sharp & Dohme Corp. Diazeniumdiolate cyclopentyl derivatives
US8623846B2 (en) 2010-05-21 2014-01-07 Merck Sharp & Dohme Corp. Diazeniumdiolate cyclohexyl derivatives
US9108920B2 (en) 2010-10-29 2015-08-18 Merck Sharp & Dohme Corp. Diazeniumdiolate heterocyclic derivatives
AU2012207528A1 (en) * 2011-01-19 2013-07-04 Merck Sharp & Dohme Corp. Diazeniumdiolate derivatives
JO3350B1 (ar) * 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
EP2704568B1 (fr) 2011-05-02 2018-01-24 Merck Sharp & Dohme Corp. Dérivés de diazèniumdiolate cyclohexyle

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0324377A2 (fr) * 1988-01-07 1989-07-19 E.I. Du Pont De Nemours And Company Imidazoles à activité bloquante de récepteur de l'angiotensine II et leurs combinaisons avec des agents diurétiques et NSaids
WO2004062568A2 (fr) * 2003-01-09 2004-07-29 Amersham Health As Agent de contraste

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0324377A2 (fr) * 1988-01-07 1989-07-19 E.I. Du Pont De Nemours And Company Imidazoles à activité bloquante de récepteur de l'angiotensine II et leurs combinaisons avec des agents diurétiques et NSaids
WO2004062568A2 (fr) * 2003-01-09 2004-07-29 Amersham Health As Agent de contraste

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARINI, DAVID J. ET AL: "Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives", JOURNAL OF MEDICINAL CHEMISTRY , 34(8), 2525-47 CODEN: JMCMAR; ISSN: 0022-2623, 1991, XP000674205 *

Also Published As

Publication number Publication date
FR2902428A1 (fr) 2007-12-21
AR061377A1 (es) 2008-08-20
FR2902428B1 (fr) 2008-08-15
WO2007144512A2 (fr) 2007-12-21

Similar Documents

Publication Publication Date Title
WO2007144512A3 (fr) Derivés diazeniumdiolates, leur procédé de préparation, leurs compositions pharmaceutiques et leur utilisation dans le domaine de l ' hypertension et des pathologies cardiovasculaires
MX2009010552A (es) Antagonistas de receptor de opioide periferico y usos de los mismos.
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
BRPI0913457A2 (pt) "composto, composição farmacêutica, e, uso do composto"
TR201903663T4 (tr) Ari̇loazol-2-i̇l si̇yanoeti̇lamino bi̇leşi̇kleri̇, bunlarin oluşturulmasi yöntemi̇ ve bunlarin kullanilmasi yöntemi̇.
WO2007107828A3 (fr) Dérivés amine
NO20063866L (no) 1,3,5-trisubstituerte 4,5-di hydro-1 H-pyrazolderivater med CB1-antagonistisk aktivitet.
MY151986A (en) Adamantyl diamide derivatives and uses of same
WO2007148185A3 (fr) 3-amino-pyrrolidino-4-lactames substitués
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
WO2009142732A3 (fr) Dérivés pyridazinone substitués comme ligands des récepteurs de l'histamine-3 (h<sb>3</sb>)
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
MY148703A (en) Polycyclic cinnamide derivatives
TN2010000091A1 (en) Substituted pyrazole derivative
BRPI0923728A2 (pt) "método de preparação de compostos de di-hidroindeno amida, suas composições farmacêuticas contendo esses compostos e uso como inibidor de proteína quinase".
CY1115919T1 (el) Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων
WO2010027236A3 (fr) Composé hétérocyclique condensé
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
WO2008156677A3 (fr) Ligands peptidiques cycliques des récepteurs de la mélanocortine
MX2009010515A (es) Antagonistas del receptor opioide periferico y usos de los mismos.
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
TN2009000040A1 (en) 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
NO20085317L (no) Imidazoazepinonforbindelser
DOP2010000329A (es) Inhibidores de la renina
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07803750

Country of ref document: EP

Kind code of ref document: A2